StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Allergen (AGN) PT Lowered to $217 at SVB Leerink
March 7, 2019 3:27 AM
SVB Leerink analyst Marc Goodman ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Allergan (AGN) Reports FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
March 11, 2019 7:32 AM